Tour ProBio's In Vivo CAR-T Facility
ProBio's CDMO services for integrated in vivo CAR-T development and manufacturing, leverages RNA-targeted lipid nanoparticles (RNA-tLNP) and targeted lentiviral vector (tLVV) technologies from gene to GMP, with capabilities spanning early development, IND-enabling CMC, clinical and commercial manufacturing.
Learn more at: https://www.probiocdmo.com/solutions/in-vivo-car-t-solutions
Learn more at: https://www.probiocdmo.com/solutions/in-vivo-car-t-solutions
00:00
00:00